Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.
Global pharma major Lupin Limited (Lupin) announced the launch of Varenicline Tablets, 0.5 mg and 1 mg,after having received an approval from the United States Food and Drug Administration (U.S. FDA).
Varenicline Tablets, 0.5 mg and 1 mg is the generic equivalent of Chantix® Tablets, 0.5 mg and 1 mg, of PF Prism C.V. It is indicated for use as an aid to smoking cessation treatment.
Varenicline Tablets (RLD Chantix®) had estimated annual sales of USD 412 million in the U.S. (IQVIA MAT November 2023).
